Introduction

The healthcare industry is witnessing a pivotal shift from traditional "sick care" to preventive healthcare, with pharmaceutical companies, policymakers, and nutrition experts playing crucial roles in this transformation. Industry leaders from PhRMA, Eli Lilly, Nestle Health Science, and MyHealthTeam recently explored how innovation in medicine, diagnostics, nutrition, and digital health is driving this evolution.

The Pharmaceutical Industry's Role in Prevention

Pharmaceutical innovation has historically been at the forefront of disease prevention, with vaccines being among the most impactful interventions. Dr. Michael Ybarra, Chief Medical Officer at PhRMA, highlighted this legacy: "We have to own the fact that we are one of the most cost-effective and important players when it comes to prevention. When I went to medical school, I learned about a number of diseases that I have never seen in clinical practice because of interventions like vaccines."

The impact extends beyond infectious diseases to chronic conditions. Dr. Ybarra noted that rheumatology offices today have "far fewer wheelchairs" than in the 1980s, thanks to innovative treatments that prevent disease progression. Similarly, HIV treatments have transformed patient outcomes dramatically.

For neurodegenerative conditions like Alzheimer's disease, early intervention is becoming increasingly important. Laura Steele, Senior Vice President at Eli Lilly, emphasized: "Time is brain. The earlier you treat, the more impactful you are for patients."

Nutrition as Preventive Medicine

Nutrition plays a vital role in the preventive healthcare ecosystem. Luis Briz, President of Professional Health Business at Nestle Health Science, articulated this perspective:

"In Nestle Health Science, we believe that food is the best medicine. We believe that the best way to avoid illness is to eat well."

The connection between gut health and overall wellness is becoming increasingly recognized, with microbiome research opening new avenues for personalized nutrition. Briz sees this as a bridge between consumer healthcare and pharma: "Areas like GI, especially microbiome, is going to be something that is going to really drive the future of personalized nutrition."

Policy and Reimbursement Challenges

Despite scientific advances, policy and reimbursement frameworks often lag behind innovation. The pharmaceutical industry faces challenges including price controls that may disincentivize certain types of preventive treatments.

"The Inflation Reduction Act put price controls on medicines, and it really disproportionately impacted small molecule medicines which often come in pill or tablet form," Dr. Ybarra explained. "Those are the types of things that oftentimes are used early on in a disease to delay progression."

For Alzheimer's treatments, diagnostic coverage remains a significant hurdle. Steele noted:

"It took years from an advanced diagnostic standpoint to get the coverage to match the innovation. And that's the key to actually identify who an appropriate patient is and who is actually appropriate for treatment."

The fragmented approach to healthcare budgeting also poses challenges. Briz highlighted how payers often take a "silo view" rather than considering the holistic impact of preventive interventions: "A lot of this is approved by the different divisions and payers that they are controlling specific budgets, and they are not looking at the holistic view of the total healthcare cost."

Healthcare System Readiness

For preventive healthcare to succeed, healthcare systems need to evolve. This includes improving patient pathways from primary care to specialists, particularly for conditions like Alzheimer's disease.

"When you look at the healthcare system today, some of our largest systems, 7 million patients start in primary care with Alzheimer's and there's a massive leakage of about 80% of those patients who never make it from a referral standpoint to an appropriate specialist," Steele explained.

Solutions include developing hub-and-spoke models to guide patients through the system, broadening the role of general practitioners in screening and diagnosis, and leveraging blood-based biomarkers for more accessible diagnostics.

Digital Health and Predictive Analytics

Digital technologies are transforming preventive healthcare through improved patient engagement and predictive analytics. Eric Peacock, CEO of MyHealthTeam, described how his company can now "predict with 90% accuracy when a patient's about to stop taking their drug," allowing for timely interventions to improve adherence.

These technologies also help identify patients who are underdiagnosed or undertreated, enabling more targeted education and outreach. For conditions with stigma attached, such as Alzheimer's disease, digital engagement can help overcome barriers to seeking care.

Key Takeaways

1) Early intervention delivers greater value: "Time is brain. The earlier you treat, the more impactful you are for patients," emphasized Laura Steele, highlighting how treating diseases at their earliest stages maximizes benefits for patients and healthcare systems.

2) Nutrition is fundamental to prevention: "We believe that food is the best medicine. We believe that the best way to avoid illness is to eat well," stated Luis Briz, pointing to the critical role of nutrition in preventive healthcare.

3) Policy frameworks must evolve to support innovation: Current reimbursement systems often fail to recognize the full value of preventive interventions, with Dr. Ybarra noting that "we need at least a decade to be able to accumulate some of this evidence" for preventive treatments.

4) Healthcare systems require structural changes: The current fragmentation between primary care and specialists creates barriers to preventive care, with 80% of potential Alzheimer's patients never reaching appropriate specialists.

5) Predictive analytics can transform patient engagement: Digital technologies now enable healthcare providers to identify at-risk patients and intervene before conditions worsen or treatment adherence fails, creating new opportunities for preventive care.

"That's one of my big missions in my team – that people are getting a flavor and a taste of all of the different components of this ecosystem between the data, the digital and the operations,"

she says. "The more we are thinking of that holistically across this whole area, the better off we're going to be anticipating and seeing around corners."

Key Takeaways

1) Start with the customer experience: "A big part of it is really starting with our customer as the first point. How do we think about that person's experience? The things that are making them frustrated or standing in their way."

2) Embrace difficult change management: "Standing true to the notion that ultimately, on the other side of those tough decisions, there's a better future for the organization and maybe even for those individuals who are impacted."

3) Adapt to the digital-native clinician: "Our clinicians are changing and that inherently means that the way we engage with those clinicians has to evolve with them."

4) Maximize each interaction: "The number of times we get in front of these clinicians nowadays is going to be a lot fewer per time period, so each one of those conversations needs to be that much better and that much more planned out."

5) Foster cross-functional thinking: "I want the entire team to be thinking about data, thinking about digital and thinking about operations, regardless of which place you are in your function."

Text

For more patient insights, including latest articles, interviews and more – click here